A review of 20 years' experience with the NovoPen® family of insulin injection devices

Clinical Drug Investigation

Volumn 26, Issue 7, 2006, Pages 367-401

  Rex, Jørn ^a   Jensen, Klaus H ^a   Lawton, Simon A ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN;

ACCURACY; DEVICE; DIABETES MELLITUS; DISEASE CONTROL; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INJECTION; INJECTION PAIN; INSULIN TREATMENT; INTERMETHOD COMPARISON; LIFESTYLE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; REVIEW; SYRINGE; TREATMENT DURATION; TREATMENT OUTCOME;

BLOOD GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INJECTIONS; INSULIN; PAIN; PATIENT COMPLIANCE; QUALITY OF LIFE;

EID: 33745238058     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626070-00001     Document Type: Review

References (59)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-53
3. Saurbrey N, Arnold-Larsen S, Moller-Jensen B, et al. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen. Diabet Med 1988; 5: 150-3
4. Saurbrey N, Berger A, Kuhl C. The NovoPen: a practical tool for simplifying multiple injection insulin therapy. Acta Paediatr Scand Suppl 1985; 320: 64-5
5. Engstrom LHK. Insulin pen for administration of isophane insulin. Practical Diabetes Int 1990; 7: 162-4
6. Berger AS, Saurbrey N, Kuhl C, et al. Clinical experience with a new device that will simplify insulin injections. Diabetes Care 1985; 8 (1): 73-6
7. Gnanalingham MG, Newland P, Smith CP. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child 1998; 79: 59-62
8. Gnanalingham MG, Newland P, Smith CP. An evaluation of NovoPen, BD-Pen, and syringe devices at small doses of insulin [abstract no. P118]. British Diabetic Association's Medical and Scientific Section Spring Meeting; 1998 Mar 25-27; Heriot Watt University, Edinburgh; 1998, S49
9. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004; 43 (1): 69-74
10. Murray DP, Keenan P, Gayer E, et al. An evaluation of a multiple-injection regimen, using the Novopen, in diabetes mellitus [abstract]. Ir J Med Sci 1988; 157: 372
11. Murray DP, Keenan P, Gayer E, et al. A randomized trial of the efficacy and acceptability of a pen injector. Diabet Med 1988; 5: 750-4
12. Arslanoglu I, Saka N, Bundak R, et al. A comparison of the use of premixed insulins in pen-injectors with conventional patient-mixed insulin treatment in children and adolescents with IDDM. Is there a decreased risk of night hypoglycemia? J Pediatr Endocrinol Metab 2000; 13: 313-8
13. Bohannon NJ. Insulin delivery using pen devices: simple-to-use tools may help young and old alike. Postgrad Med 1999; 106: 57-8, 61-4, 68
14. Gall MA, Mathiesen ER, Skott P, et al. Effect of multiple insulin injections with a pen injector on metabolic control and general well-being in insulin-dependent diabetes mellitus. Diabetes Res 1989; 11: 97-101
15. Small M, MacRury S, Boal A, et al. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus. Diabetes Res 1988; 8: 85-9
16. Tallroth G, Karlson B, Nilsson A, et al. The influence of different insulin regimens on quality of life and metabolic control in insulin-dependent diabetics. Diabetes Res Clin Pract 1989; 6: 37-43
17. Tubiana-Rufi N, Levy-Marchal C, Mugnier E, et al. Long term feasibility of multiple daily injections with insulin pens in children and adolescents with diabetes. Eur J Pediatr 1989; 149: 80-3
18. Dahl-Jorgensen K, Hanssen KF, Mosand R, et al. The "insulin pen": comparison with multiple injection treatment with syringe. Practical Diabetes Int 1986; 3: 90-1
19. Henderson MJ, Tindall H. Evaluation of consumer satisfaction and quality of life in patients changing to Novopen II. Practical Diabetes Int 1990; 7: 206-8
20. Walters DP, Smith PA, Marteau TM, et al. Experience with NovoPen, an injection device using cartridged insulin, for diabetic patients. Diabet Med 1985; 2: 496-7
21. Masson EA, McAughey D, Davies D, et al. The use of multiple insulin injection therapy using 'NovoPen' in a routine outpatient setting. Diabetes Res Clin Pract 1989; 7: 57-60
22. Stewart KM, Wilson MF, Rider JM. Insulin delivery devices. J Pharm Pract 2004; 17: 20-8
23. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery sytems versus a vial and syringe. Clin Ther 1998; 20: 486-96
24. Kadiri A, Chraibi A, Marouan F, et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998; 41: 15-23
25. Houtzagers CM, Berntzen PA, van der Stap H, et al. Efficacy and acceptance of two intensified conventional insulin therapy regimens: a long-term cross-over comparison. Diabet Med 1989; 6: 416-21
26. Houtzagers CM, Visser AP, Berntzen PA, et al. Multiple daily insulin injections improve self-confidence. Diabet Med 1989; 6: 512-9
27. Kolendorf K, Beck-Nielsen H, Oxenboll B. Clinical experience with NovoPen® II and insulin Protaphane® HM Penfill®. Postgrad Med J 1988; 64 Suppl. 3: 14-6
28. Valk NK, Cerny G, Sieber J, et al. Efficacy and safety performance of the Innovo insulin doser. Diabetes Technol Ther 2004; 6: 53-8
29. Su CC, Chen HS, Lin HD. Glycemic control with different premixed insulin in Taiwanese people with type two diabetes mellitus. J Chin Med Assoc 2003; 66: 155-9
30. Katoulis EC, Makris GS, Ioannou JC, et al. Longterm (2 years) comparison of basal-bolus Novopen and conventional regime in insulin dependent diabetics [abstract]. Diabetes 1991; 40: 456
31. Spijker AJ, Hoekstra JBL, Erkelens DW. The insulin pen: a new device for multiple insulin injections. Transplant Proc 1986; 18: 1689-90
32. Seshaiah V, Rais N, John L, et al. NovoPen® 1.5 in Indian women with gestational diabetes mellitus [abstract no. 1302]. 16th International Diabetes Federation Congress; 1997 July 20-25; Helsinki. 1997: A331
33. Bak JF, Nielsen OH, Pedersen O, et al. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. Diabetes Res 1987; 6: 155-8
34. Salardi S, Cacciari E, Zucchini S, et al. Modifications of metabolic control in type 1 diabetic children and adolescents: experience over the last 20 years. J Pediatr Endocrinol Metab 1997; 10: 569-78
35. Chang G, Chia J, Rahayu S, et al. Evaluating the use of the Novopen 3 insulin delivery sytem in Singaporean Diabetes subjects [abstract no. P158]. 17th International Diabetes Federation Congress; 2000 Nov 5-10; Mexico City. 2000: S20
36. Jefferson IG, Marteau TM, Smith MA, et al. A multiple injection regimen using an insulin injection pen and pre-filled cartridged soluble human insulin in adolescents with diabetes. Diabet Med 1985; 2: 493-5
37. Jensen T, Moller L, Ortved Andersen O. Metabolic control and patient acceptability of multiple insulin injections using NovoPen cartridge-packed insulin. Practical Diabetes Int 1986; 3: 302-6
38. Jenkins HR, Hinton JL, Williams H, et al. A study of metabolic control and patient acceptability in adolescent diabetics using the NovoPen. Practical Diabetes Int 1989; 6: 14-5
39. Distiller LA, Robertson LI, Moore R, et al. A bolus/basal multiple injection regimen in type I diabetes: a multicentre trial using a new 'fountain-pen' device for short-acting human insulin as well as long-acting human insulin. S Afr Med J 1987; 71: 749-52
40. Dinneen SF, Cronin CC, O'Sullivan DJ. Long term efficacy of a pen injector. Ir J Med Sci 1991; 160: 286-7
41. Houtzagers CM, van der Velde EA. Multiple daily insulin injections: a multicentre study on acceptability and efficacy. Neth J Med 1988; 33: 16-25
42. Dunn PJ, Jury DR. Multiple dose insulin regimen using the NovoPen: initial experience and approximate dose requirements. N Z Med J 1986; 99: 226-30
43. Hyer SL, Froyd HE, Kohner EM. Effect of the NovoPen on glycemic control and patient independence in diabetics with visual impairment. Practical Diabetes Int 1988; 5: 197-9
44. Fövényi J, Szoverffy G, Thaisz E, et al. Experiences with functional insulin substitution: a follow-up study on control and patient compliance. Acta Med Hung 1992; 49: 53-64
45. Mora Mora PF, Wilk T, Shaw KM. Use of NovoPen 3® in a homeless population: efficacy, preference and biosafety [abstract no. 917P]. 60th Scientific Sessions of the American Diabetes Association; 2000 Jun 9-13; San Antonio (TX). 2000: A221
46. Wilk T, Mora PF, Chaney S, et al. Use of an insulin pen by homeless patients with diabetes mellitus. J Am Acad Nurse Pract 2002; 14: 372-9
47. Romanian Young Diabetics Study Team (RYDST). Mixtard 30 HM Penfill insulin treatment in selected young insulin-dependent diabetes mellitus patients. Romanian Young Diabetics Study Team (RYDST). Rom J Intern Med 1997; 35: 99-113
48. Hardy KJ, Jones KE, Gill GV, et al. NovoPen worsens blood glucose control in female diabetics [abstract]. Diabet Med 1990; 7 Suppl 1: 23
49. Sommerfeldt E, Oygard R, Sander J, et al. Novopen: a useful aid also for blind diabetic patients. Diabetes Care 1989; 12 (4): 306-7
50. Lunt H, Smith RB. Multiple dose insulin regimen using the NovoPen. N Z Med J 1986; 99 (802): 379
51. Santiago OM, Khutoryansky NM, Bilbo CM, et al. Accuracy and precision of the NovoPen® 3 insulin delivery device after mechanical and temperature stresses. Endocr Pract 2002; 8 (5): 351-5
52. Gordon D, Wilson M, Paterson KR, et al. An assessment of the accuracy of NovoPen 1 delivery after prolonged use. Diabet Med 1990; 7 (4): 364-6
53. Lteife AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999; 22: 137-40
54. Newman KD, Weaver MT. Insulin measurement and preparation among diabetic patients at a county hospital. Nurse Pract 1994; 19 (3): 44-5, 48
55. Costello C, Calabrese G, Fedele D, et al. Use of premixed insulin among the elderly: reduction of errors in patient preparation of mixtures. Diabetes Care 1992; 15 (11): 1628-30
56. Diglas J, Feinbock C, Winkler F, et al. Reduced pain perception with Pen Mate™, an automatic needle insertion device for use with an insulin pen. Practical Diabetes Int 1999; 16: 39-41
57. Hörnquist JO, Wikby A, Andersson P-O, et al. Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations. Diabetes Res Clin Pract 1990; 10: 221-30
58. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care 1997; 20 (3): 292-8
59. Liebermeister H, Sammler A. Problems of the elderly, insulin injecting diabetic patients in ambulatory care [in German]. Versicherungsmedizin 1990; 42 (2): 59-64